Jane Street
DWTX

Jane Street’s Dogwood Therapeutics DWTX Stock Holding History

Jane Street’s Portfolio DWTX Stock Details DWTX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q4 		– Sell
-1,121
Closed -$4.76K – 10865
2024
Q3 		$4.76K Buy
+1,121
New +$5.81K ﹤0.01% 9405
2024
Q2 		– Sell
-680
Closed -$8.14K – 10356
2024
Q1 		$8.14K Buy
+680
New +$7.63K ﹤0.01% 8979
2023
Q2 		– Sell
-722
Closed -$6.64K – 9729
2023
Q1 		$6.64K Buy
+722
New +$5.74K ﹤0.01% 8785
2021
Q1 		– Sell
-3,809
Closed -$715K – 9675
2020
Q4 		$715K Buy
+3,809
New +$918K ﹤0.01% 5196

Other funds holding DWTX

UBS Group
UBS Group Zurich, Switzerland $666B AUM 30.12% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
TRCT
Tower Research Capital (TRC) New York $3.85B AUM 32.11% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
Northwestern Mutual Wealth Management
Northwestern Mutual Wealth Management Milwaukee, Wisconsin $162B AUM 16.35% 1-Year Est. Return
AWM
Activest Wealth Management Aventure, Florida $518M AUM 44.34% 1-Year Est. Return
Group One Trading
Group One Trading Chicago, Illinois $52.2B AUM 104.56% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Bank of America
Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return
SS
SBI Securities Tokyo, Japan $4.4B AUM 74.26% 1-Year Est. Return

Jane Street's DWTX Position: Q4 2024 in Review

Jane Street sold out of Dogwood Therapeutics (DWTX) in Q4 2024, closing a stake of 1,121 shares — an estimated $4.76K sold.

Jane Street first reported a position in DWTX in Q4 2020 and held it in 4 quarters. The position peaked at $715K in Q4 2020. 10 funds tracked by Wall St. Rank hold DWTX as of Q4 2024.

  • Jane Street reported no remaining Dogwood Therapeutics position as of Q4 2024 after selling out during the quarter.
  • Jane Street sold 1,121 Dogwood Therapeutics shares in Q4 2024, an estimated $4.76K.
  • Jane Street first reported a position in Dogwood Therapeutics in Q4 2020 and held it in 4 quarters.
  • Jane Street's Dogwood Therapeutics position peaked at $715K in Q4 2020.
  • 10 funds tracked by Wall St. Rank held Dogwood Therapeutics as of Q4 2024.

Based on Jane Street's 13F filing for Q4 2024, filed 14 Feb 2025.